U.S. Supreme Court Rejects Pharma Industry Challenge to Medicare Drug Price Plan
The U.S. Supreme Court on Monday declined to hear a major challenge from leading pharmaceutical companies against the Medicare drug price negotiation program introduced under former President Joe Biden’s Inflation Reduction Act of 2022....